SCHEMBL2170959

SCHEMBL2170959

O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)C1CC(Cc2ccccc2C(F)(F)F)CN1C(=O)Cn1cncn1

nearest known ligand 0.78

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 9/20 0.78
CYP2C9 P11712 6/20 0.78
CYP2D6 P10635 6/20 0.78
CYP3A4 P08684 3/20 0.76
CFD P00746 5/20 0.36
CYP19A1 P11511 1/20 0.34
CSF1R P07333 1/20 0.34
PDGFRB P09619 1/20 0.34
KIT P10721 1/20 0.34
PDGFRA P16234 1/20 0.34
FLT3 P36888 1/20 0.34
CFTR P13569 1/20 0.34
MMP1 P03956 1/20 0.33
ADAM17 P78536 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1372946 1.00 S1PR1 (0.78) S1PR1CYP2C9CYP2D6CYP3A4CFD
SCHEMBL1372649 0.91 S1PR1 (0.83) S1PR1CYP2C9CYP2D6CYP3A4CYP19A1
SCHEMBL1371497 0.90 S1PR1 (0.80) S1PR1CYP2C9CYP2D6CYP3A4CYP19A1
SCHEMBL2170406 0.90 S1PR1 (0.80) S1PR1CYP2C9CYP2D6CYP3A4CYP19A1
SCHEMBL1375432 0.90 S1PR1 (0.80) S1PR1CYP2C9CYP2D6CYP3A4CFD
SCHEMBL2170438 0.90 S1PR1 (0.80) S1PR1CYP2C9CYP2D6CYP3A4CFD
SCHEMBL1373685 0.88 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4CYP19A1
SCHEMBL2170080 0.88 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4CYP19A1
SCHEMBL1374243 0.87 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4CFD
SCHEMBL1374743 0.87 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4CFD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP disclosed
WO-2010045580-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed